Clinical Efficacy of Pneumococcal Conjugate 13-valent Vaccine in Young Children

• Główni autorzy: S. M. Kharit (Autor), I. V. Fridman (Autor), A. N. Pavlyukova (Autor), E. Ya. Frolova (Autor), A. A. Ruleva (Autor)
• Format: Książka
• Wydane: Union of pediatricians of Russia, 2016-12-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.
• Notes: 1727-5776; 2500-3089; 10.15690/pf.v13i5.1639
• Keywords: children; pneumococcal infection; vaccination; conjugated 13-valent vaccine; acute respiratory infection; otitis; pneumonia; Pediatrics; RJ1-570; Therapeutics. Pharmacology; RM1-950
• Source: Педиатрическая фармакология, Vol 13, Iss 5, Pp 443-447 (2016)

Objective: Our aim was to study the clinical efficacy of pneumococcal conjugate 13-valent vaccine (PCV13) in children aged less than 3 years.Methods: retrospective comparative study of the incidence of acute respiratory infections (ARI), otitis and pneumonia during the first three years of life in 184 children vaccinated with PKV13 and 186 unvaccinated peers.Results: 91 of 184 children (49.4%) were vaccinated during the 1st year of life, 61 (33.2%) - during the 2nd year, and 32 (17.4%) - during the 3rd year. Number of ARI per 1 child among children vaccinated in the 1st year of life was 5.5 times less than among unvaccinated children (0.42 and 2.31 cases); frequency of otitis during the second year of life was 6.8 times less (7.6% and 52.1%, р < 0,01), and during the third - 34.7 times less (1.1% and 38.2%, р < 0,01). All children vaccinated before the age of 1 were 6.3 times less (1.1% and 6.9%) ill with pneumonias. Additionally it was noted that number of ARI per 1 person among children, vaccinated during the 1st year of life, during the third year of life was lower than among children vaccinated later (0.42; 1.02; 2.03 respectively). There also was a significant in otitis number between children vaccinated during the first and the third years of life (1.1 and 15.6% р < 0,01).Conclusion: to reduce the incidence of ARI, otitis and pneumonia in children, it is necessary to vaccinate children with PCV13 in the age under 1 year. «Catching up» immunization of the second and third years of life is effective, but to a lesser extent.